Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Insights from 2023 ASCO® Annual Meeting
H

ASCO® 2023 Insights: "PERSIST-2 Landmark OS Analysis - Spleen Volume Reduction Predicts OS in Myelofibrosis Pts on Pacritinib, But Not Best Available Therapy"

By Insights from 2023 ASCO® Annual Meeting FEATURING Helen Ajufo
By Insights from 2023 ASCO® Annual Meeting FEATURING Helen Ajufo
303 views
June 9, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
MPN
04:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PERSIST-2 Landmark OS Analysis - Spleen V…

Feat. H. Ajufo